Analysis of outcome in retrieved dropout patients in a Rivastigmine vs Placebo, 26-week, Alzheimer disease trial

Martin Farlow, Steven Potkin, Barbara Koumaras, Jeffrey Veach, Dario Mirski

Research output: Contribution to journalArticle

59 Scopus citations

Fingerprint Dive into the research topics of 'Analysis of outcome in retrieved dropout patients in a Rivastigmine vs Placebo, 26-week, Alzheimer disease trial'. Together they form a unique fingerprint.

Arts & Humanities

Medicine & Life Sciences